Ekso Bionics Holdings, Inc. (EKSO) NASDAQ

11.80

+0.15(+1.29%)

Updated at May 15 04:00PM

Currency In USD

Valuation

Market Cap20.96M
Enterprise Value22.43M
P/E Ratio-2.68
PEG Ratio-0.09
Price/Sales Ratio2.48
Price/Book Ratio7.32
Enterprise/Revenue2.5
Enterprise/EBITDA-2.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.36
Operating Margin-1.34

Management Effectiveness

Return On Assets-0.8
Return On Equity-1.77

Income Statement

Revenue12.8M
Revenue/Share3.25
Gross Profit6.85M
EBITDA-9.81M
Net Income-11.7M
Diluted EPS-4.91

Balance Sheet

Total Cash3.99M
Total Cash/Share1.12
Total Debt4.32M
Total Debt/Equity0.75
Current Ratio1.55
Book Value Per Share1.61

Price History

52-Week Change167.57
52-Week High13.5
52-Week Low2.73
Moving Average 50 Days10.62
Moving Average 200 Days6.93

Statistics

Average Volume78,942
Shares Outstanding2.43M
% Held by Institutions37.56

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateJune 02, 2025